ICIF is a cancer-focused impact fund taking a patient-centered approach in investing across the entire cancer care continuum — from prevention to diagnosis to treatment and ongoing care.
Our fund is indication-agnostic within the field of Cancer and will consider early-stage opportunities in the diagnostic, biopharmaceutical, healthcare IT (HCIT) and Artificial Intelligence (AI), and medical technology sectors.
The International Cancer Impact Fund’s (ICIF) vision is that every patient with cancer deserves a cure. ICIF aims to efficiently channel capital into the most promising private oncology companies developing the next generation of cancer innovations and provides strategic support to portfolio companies to maximize their value, probability of success, and impact. We want to advance innovation and the delivery of cancer care from a patient-centered point of view to improve patient outcomes.
ICIF will be the only impact fund investing across the entire cancer care continuum — from prevention to diagnosis to treatment and ongoing care. ICIF will consider opportunities in diagnostics, biopharmaceuticals, healthcare IT (HCIT), Artificial Intelligence (AI), and medical technology. The fund will target a 50-75% allocation towards drug therapeutics with a focus on IND-enabled through Phase I staged assets and equivalent
The ICIF team includes highly experienced venture capitalists, accomplished oncology clinicians, researchers, center administrators, and corporate executives. Our team is actively involved in deal sourcing, analysis, portfolio management, and dedicating their immense talents for a common cause — finding, funding, and developing new and more effective treatments for cancer.
ICIF was founded after years of working in the business and investment industry. We are motivated by our mission, powered by data, and driven by results. Our goal is to help entrepreneurs turn their own ideas and visions into successful companies with fundraising and networking guidance. We are constantly looking for ambitious and visionary partners with the drive and flexibility to take their companies to the next level. For details about our investment process as well as our level of involvement, get in touch with us.
LEADERSHIP + INVESTMENT TEAM
The venture team oversees deal flow, fund administration, structuring investments, and is an instrumental member of the investment committee.
SCIENTIFIC ADVISORY BOARD
A unique medical and scientific advisory board provides oversight of scientific due diligence process, and ongoing scientific, regulatory and technical support and guidance post-investment to portfolio companies.
ICIF is a mission-driven impact fund committed to improving outcomes for patients with cancer because we are individuals who have witnessed firsthand the devastating effects of cancer. As a Cancer Impact Fund, the General Partnership will make donations to Patient Advocacy Groups (PAG) and Centers of Excellence (COE) that are at the forefront of cancer research and innovation. As part of our commitment to Cancer research and innovation, ICIF will partner with Centers of Excellence throughout the United States to augment the fund’s pipeline volume and validation, due diligence assistance, R&D evaluation, alliance management, and initial product roll-out. It is these centers that will receive a portion of the donation once an exit is realized.
Interested in contacting the International Cancer Impact Fund about an investment opportunity, partnership or to learn more?
For all inquiries, please call our main reception
between 9:00am - 6:00pm EST
(617) 235 - 7232